NeuroPace NPCE
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001193125-22-006746
- Reports quarterly results (2.02)
- Makes a Regulation FD disclosure (7.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- ClearPoint Neuro CLPT public float $328M, Jun 30, 2025
- Outset Medical OM public float $335M, Jun 30, 2025
- SS Innovations International SSII public float $270M, Jun 30, 2025
- EBR Systems EBRCZ public float $351M, Jun 30, 2025
- Treace Medical Concepts TMCI public float $266M, Jun 30, 2025
